During the past decade, SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen" are "Brain and Central Nervous System Tumors" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Isocitrate Dehydrogenase" (1 trials), "Leukemia" (1 trials) and "Leukemia, Myeloid" (1 trials). Many other conditions were trialed in "SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen" in a lesser frequency.

Most popular intervention types in "SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen" are "Drug" (5 trials), "Radiation" (3 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (3 trials), "conventional surgery" (2 trials), "cyclophosphamide" (2 trials), "doxorubicin hydrochloride" (2 trials) and "ifosfamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen" are 6 trials for "All" genders.

Currently, there are NaN active trials in "SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".